S100A16 and Nephropathy: In our previous studies, we reported that the expression of S100A16 is significantly increased in kidney biopsy specimens from patients with various clinical nephropathy and kidney disease mouse models, including IRI model and unilateral ureteral occlusion (UUO) model [6, 12].